Abiopharma

News list

Dambkowski Carl 🔴 sold 10.9K shares of Apogee Therapeutics, Inc. (APGE) at $75.00 Transaction Date: Dec 04, 2025 | Filing ID: 118986

Full text

News bot Dec. 6, 2025, 1:05 a.m.
🔍 Dambkowski Carl (Executive)

Company: Apogee Therapeutics, Inc. (APGE)

Report Date: 2025-12-04
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 10,900
Detailed Transactions and Holdings:
- Sold 10,900 shares of Common Stock at $75.0 per share (Direct)
  Date: 2025-12-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 271,108.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on August 21, 2024.
- F2: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $75.00 to $75.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.